You can survive without Flash. And now Adobe might have to

Apple has hired Adobe's CTO. Is this the death of Flash?

The Chief Technology Officer of Adobe, Kevin Lynch, has been hired by Apple to be the new VP of Technology. Is is time to start celebrating the death of Flash?

In his old job, Lynch was the chief proponent of Flash, developed by Macromedia, his old employers, before the company was bought by Adobe and he earned his CTO role. And that role, as time went by, consisted more and more of attacking the most outspoken anti-Flash company in technology: Apple.

When the iPhone was launched in 2007, it was mocked for not having Flash installed. Adobe could reasonably claim that, for a "full" web experience, you needed its software. Of course, in 2007, the idea of any smartphone being able to run the incredibly poorly engineered Flash software was pretty much laughable, and although some Android phones came out the year later with a mobile version of Flash, they largely vindicated Apple's decision. When the plugin was turned on, they ran slowly, crashed frequently, and hoovered up battery life at an alarming rate.

The real shots were fired in 2010, when the iPad was launched. Apple's vision for the iPad was clearly a full, PC-quality version of the web. And if that vision didn't have Flash in it, it never would.

But Lynch carried on fighting, writing shortly after the launch of the iPad that:

Some have been surprised at the lack of inclusion of Flash Player on a recent magical device. […]

We are now on the verge of delivering Flash Player 10.1 for smartphones with all but one of the top manufacturers. This includes Google’s Android, RIM’s Blackberry, Nokia, Palm Pre and many others across form factors including not only smartphones but also tablets, netbooks, and internet-connected TVs. Flash in the browser provides a competitive advantage to these devices because it will enable their customers to browse the whole Web.

Since then, Palm has gone bust, Google has dropped support for Flash, and Nokia has adopted Windows Phone for its smartphones – which doesn't have Flash. Only BlackBerry is left supporting the plugin, although even it turns Flash off by default. And if your last hope rests on BlackBerry, you may as well start price-matching undertakers now.

Because here's the secret: you don't need Flash. And that's not "you don't need Flash on mobile devices". Unless you play a whole bunch of Flash games – and I'm not judging you if you do (I am totally judging you if you do) – then uninstalling Flash Player will make your browser quicker, less crash-prone and less ad-heavy.

I haven't had Flash on my Mac for 6 months. Nearly every site that uses Flash only uses it for adverts. And more and more things which used to require Flash now have a fall-back which works on modern browsers. Almost every video site will now happily play video through HTML5, and the days of functionality being limited to flash for e-commerce are over. Embarassingly, the biggest exception is the BBC iPlayer, which still only plays Flash video.

So there are still times when Flash makes things easier, and my personal fallback is an installation of Chrome. Google uses its own Flash player, which means that you can have a browser which uses Flash without it infecting everything else – and without allowing any of Adobe's other crudware onto your system (yes, I'm looking at you, Adobe Updater).

But the real question is, if Lynch's legacy at Adobe is the slow death of one is its only consumer products, what does Apple want with him.

An advert taken out by Adobe in May 2010, aimed at convincing Apple to include Flash on the iPad. It failed. Photograph: Getty Images

Alex Hern is a technology reporter for the Guardian. He was formerly staff writer at the New Statesman. You should follow Alex on Twitter.

Getty
Show Hide image

Relax – there’s new evidence that mindfulness actually works

The relaxation therapy could prevent relapses in sufferers of depression, according to a new study.

If there’s one thing that can be said of buzzwords, it’s that they almost always fall by the wayside in the end. Yet in the field of mental health, one buzzword has survived the best efforts of critics and naysayers – “mindfulness”.

First coined by Dr Jon Kabat-Zinn from the University of Massachusetts Medical School, the term mindfulness was initially characterised as a state of mind that would enable someone to pay “attention on purpose” to the present moment. Modern secular society seems to have embraced it as a form of meditation. Everything from exercise to breathing now has an associated mindfulness manual attached.

However, not everyone is convinced. For example, the recent phenomenon of adult colouring books – devised to promote mindfulness and serve as a form of therapeutic escapism – has been criticised by therapists as over-hyped and not necessarily helpful.

Meanwhile, sceptics have pointed out an alleged bias in the publishing of positive findings from trials using mindfulness as a form of mental health therapy. Researchers at McGill University in Canada “found that scientists reported positive findings 60 per cent more often than is statistically likely” after analysing 124 different published trials involving mindfulness as a form of mental health therapy. In some cases, the practice has even had a reverse effect, inducing anxiety, pain or panic.

However, a new study published in the journal JAMA Psychiatry seems to demonstrate that mindfulness-based cognitive therapy (MBCT) can be a potent treatment in preventing and managing relapse into major depression. Led by the University of Oxford, the study’s researchers conducted the largest meta-analysis (an analysis of various different studies) to date on the therapy’s impact on recurrent depression.

The particular form of mindfulness-based cognitive therapy that was used aimed to equip patients with the skills required to successfully recognise and repel the thoughts and feelings they most commonly associated with the state of depression, in order to prevent any future relapse.

According to the study, “the MBCT course consists of guided mindfulness practices, group discussion and other cognitive behavioural exercises. Participants receiving MBCT typically attended eight 2-2.5 hour group sessions alongside daily home practice.”

Using anonymous patient data from nine randomised trials involving 1,258 participants, researchers found that 38 per cent of those who received mindfulness-based therapy experienced a depressive relapse, in comparison to 49 per cent of patients who didn’t receive treatment. The patient data covered age, sex and level of education – key inclusions, as the meta-analysis was able to show no significant influence by these factors on the therapy’s performance.

The most prominent form of remedy currently available for mental health patients is anti-depressant medication. Four of the nine randomised trials comparatively assessed the impact of therapy alongside medication, to deduce if a combination of therapy with varying doses of medication was more beneficial than medication alone. The patients from the study who received mindfulness therapy along with continued, reduced or discontinued medication were less likely to fall back into depression than patients on maintenance anti-depressants alone. This helps legitimise mindfulness as an option in combating depression’s debilitating effects and reinforces its efficacy, whether it is taken up with or without anti-depressants.

Willem Kuyken, Professor of Clinical Psychology at the Oxford Mindfulness Centre and lead author of the study, called the results “very heartening”. “While MBCT is not a panacea, it does clearly offer those with a substantial history of depression a new approach to learning skills to stay well in the long-term.

“It offers people a safe and empowering treatment choice alongside other mainstay approaches such as cognitive-behavioural therapy and maintenance antidepressants. We need to do more research, however, to get recovery rates closer to 100 per cent and to help prevent the first onset of depression, earlier in life. These are programmes of work we are pursuing at the University of Oxford and with our collaborators around the world."

Though the findings will certainly reinvigorate confidence in mindfulness, Richard Byng from the University of Plymouth and one of the co-authors said, “clinicians need to be cautiously optimistic when tapering off antidepressant medication, and treat each patient as an individual who may or may not benefit from both MBCT and other effective treatments."